Founded by Dr. Todd Lewis, the organization reflects a process-driven approach shaped by both industry experience and ...

A pioneering test is improving early diagnosis for people with hereditary cancer caused by a genetic condition. Just over 30 ...

Oxford Nanopore Technologies has signed a partnership with artificial intelligence developer SeqOne to support its next-generation sequencing approach in clinical diagnostic testing. The goal will be ...

CLEVELAND, Ohio—Case Western Reserve University researchers have developed a new method of DNA testing—one they say could greatly expand its uses in medical research. The method rapidly and accurately ...

A pioneering genetic test is improving early diagnosis and treatment for people with hereditary cancer caused by a genetic condition. The test, developed with the help of Newcastle University ...

According to Needham, Lucid Diagnostics Inc. (NASDAQ:LUCD) is likely to receive approval for EsoGuard testing-related Medicare reimbursement, which would boost testing volumes. The Lucid Diagnostics ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as ...

Researchers at the Icahn School of Medicine at Mount Sinai have reported promising findings that may help redefine treatment for patients with muscle-invasive bladder cancer, a potentially aggressive ...

Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "DNA Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's offering.

Scientists have uncovered new DNA-binding proteins from some of the most extreme environments on Earth and shown that they ...